BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33896058)

  • 21. Refining the 22q11.2 deletion breakpoints in DiGeorge syndrome by aCGH.
    Bittel DC; Yu S; Newkirk H; Kibiryeva N; Holt A; Butler MG; Cooley LD
    Cytogenet Genome Res; 2009; 124(2):113-20. PubMed ID: 19420922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytogenetic and molecular analysis of a t(1;22)(p36;q11.2) in a rhabdoid tumor with a putative homozygous deletion of chromosome 22.
    Rosty C; Peter M; Zucman J; Validire P; Delattre O; Aurias A
    Genes Chromosomes Cancer; 1998 Feb; 21(2):82-9. PubMed ID: 9491318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genomic analysis using high-density single nucleotide polymorphism-based oligonucleotide arrays and multiplex ligation-dependent probe amplification provides a comprehensive analysis of INI1/SMARCB1 in malignant rhabdoid tumors.
    Jackson EM; Sievert AJ; Gai X; Hakonarson H; Judkins AR; Tooke L; Perin JC; Xie H; Shaikh TH; Biegel JA
    Clin Cancer Res; 2009 Mar; 15(6):1923-30. PubMed ID: 19276269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atypical chromosome 22q11.2 deletions are complex rearrangements and have different mechanistic origins.
    Vervoort L; Demaerel W; Rengifo LY; Odrzywolski A; Vergaelen E; Hestand MS; Breckpot J; Devriendt K; Swillen A; McDonald-McGinn DM; Fiksinski AM; Zinkstok JR; Morrow BE; Heung T; Vorstman JAS; Bassett AS; Chow EWC; Shashi V; ; ; Vermeesch JR
    Hum Mol Genet; 2019 Nov; 28(22):3724-3733. PubMed ID: 31884517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. hSNF5/INI1 inactivation is mainly associated with homozygous deletions and mitotic recombinations in rhabdoid tumors.
    Rousseau-Merck MF; Versteege I; Legrand I; Couturier J; Mairal A; Delattre O; Aurias A
    Cancer Res; 1999 Jul; 59(13):3152-6. PubMed ID: 10397258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chromosome 22q dosage in composite extrarenal rhabdoid tumors: clonal evolution or a phenotypic mimic?
    Fuller CE; Pfeifer J; Humphrey P; Bruch LA; Dehner LP; Perry A
    Hum Pathol; 2001 Oct; 32(10):1102-8. PubMed ID: 11679945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transposable element insertion as a mechanism of SMARCB1 inactivation in atypical teratoid/rhabdoid tumor.
    Thomas C; Oehl-Huber K; Bens S; Soschinski P; Koch A; Nemes K; Oyen F; Kordes U; Kool M; Frühwald MC; Hasselblatt M; Siebert R
    Genes Chromosomes Cancer; 2021 Aug; 60(8):586-590. PubMed ID: 33896072
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cribriform neuroepithelial tumor: molecular characterization of a SMARCB1-deficient non-rhabdoid tumor with favorable long-term outcome.
    Johann PD; Hovestadt V; Thomas C; Jeibmann A; Heß K; Bens S; Oyen F; Hawkins C; Pierson CR; Aldape K; Kim SP; Widing E; Sumerauer D; Hauser P; van Landeghem F; Ryzhova M; Korshunov A; Capper D; Jones DTW; Pfister SM; Schneppenheim R; Siebert R; Paulus W; Frühwald MC; Kool M; Hasselblatt M
    Brain Pathol; 2017 Jul; 27(4):411-418. PubMed ID: 27380723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chromosome mechanisms and INI1 inactivation in human and mouse rhabdoid tumors.
    Rousseau-Merck MF; Fiette L; Klochendler-Yeivin A; Delattre O; Aurias A
    Cancer Genet Cytogenet; 2005 Mar; 157(2):127-33. PubMed ID: 15721633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conventional chondrosarcoma in a survivor of rhabdoid tumor: enlarging the spectrum of tumors associated with SMARCB1 germline mutations.
    Forest F; David A; Arrufat S; Pierron G; Ranchere-Vince D; Stephan JL; Clemenson A; Delattre O; Bourdeaut F
    Am J Surg Pathol; 2012 Dec; 36(12):1892-6. PubMed ID: 23154773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Timing of Smarcb1 and Nf2 inactivation determines schwannoma versus rhabdoid tumor development.
    Vitte J; Gao F; Coppola G; Judkins AR; Giovannini M
    Nat Commun; 2017 Aug; 8(1):300. PubMed ID: 28824165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular genetics of atypical teratoid/rhabdoid tumor.
    Biegel JA
    Neurosurg Focus; 2006 Jan; 20(1):E11. PubMed ID: 16459991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors.
    Biegel JA; Tan L; Zhang F; Wainwright L; Russo P; Rorke LB
    Clin Cancer Res; 2002 Nov; 8(11):3461-7. PubMed ID: 12429635
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atypical teratoid/rhabdoid tumor of the central nervous system: report on workshop.
    Packer RJ; Biegel JA; Blaney S; Finlay J; Geyer JR; Heideman R; Hilden J; Janss AJ; Kun L; Vezina G; Rorke LB; Smith M
    J Pediatr Hematol Oncol; 2002; 24(5):337-42. PubMed ID: 12142780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of meiotic recombination in 22q11.2, a region that frequently undergoes deletions and duplications.
    Torres-Juan L; Rosell J; Sánchez-de-la-Torre M; Fibla J; Heine-Suñer D
    BMC Med Genet; 2007 Apr; 8():14. PubMed ID: 17397557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular mechanisms and diagnosis of chromosome 22q11.2 rearrangements.
    Emanuel BS
    Dev Disabil Res Rev; 2008; 14(1):11-8. PubMed ID: 18636632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cat eye syndrome chromosome breakpoint clustering: identification of two intervals also associated with 22q11 deletion syndrome breakpoints.
    McTaggart KE; Budarf ML; Driscoll DA; Emanuel BS; Ferreira P; McDermid HE
    Cytogenet Cell Genet; 1998; 81(3-4):222-8. PubMed ID: 9730608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cancer Surveillance in Gorlin Syndrome and Rhabdoid Tumor Predisposition Syndrome.
    Foulkes WD; Kamihara J; Evans DGR; Brugières L; Bourdeaut F; Molenaar JJ; Walsh MF; Brodeur GM; Diller L
    Clin Cancer Res; 2017 Jun; 23(12):e62-e67. PubMed ID: 28620006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rhabdoid tumor of the kidney is a component of the rhabdoid predisposition syndrome.
    Lee HY; Yoon CS; Sevenet N; Rajalingam V; Delattre O; Walford NQ
    Pediatr Dev Pathol; 2002; 5(4):395-9. PubMed ID: 12016529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detailed analysis of 22q11.2 with a high density MLPA probe set.
    Jalali GR; Vorstman JA; Errami A; Vijzelaar R; Biegel J; Shaikh T; Emanuel BS
    Hum Mutat; 2008 Mar; 29(3):433-40. PubMed ID: 18033723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.